Two-visit cumulative HbA1c–adiposity exposure and incident cardiovascular disease in Chinese adults: a prospective community-based cohort study
Background Hyperglycemia and excess adiposity are closely related cardiovascular risk factors. We examined the associations of cumulative HbA1c and HbA1c–adiposity products measured over three years with subsequent cardiovascular disease (CVD) in Chinese adults. Methods This prospective study included 4,440 participants from the Dalian subcohort of the China Cardiometabolic Disease and Cancer Cohort Study who attended examinations in 2011 and 2014 and were free of CVD in 2014. Cumulative exposures were calculated from the two measurements of HbA1c, five adiposity indices and their products. Follow-up began in 2014. Multivariable Cox models, restricted cubic splines (RCS), joint exposure categories and sensitivity analyses were used to assess the associations. We also compared the products with their individual components and examined seven-year prediction performance. Results During a median follow-up of 7.21 years, 571 participants developed CVD. The adjusted hazard ratio (HR) per standard deviation increase was 1.13 (95% confidence interval [CI] 1.04–1.22) for cumulative HbA1c and 1.15–1.17 for the five cumulative products. These associations remained significant after false discovery rate correction. Participants with both high cumulative HbA1c and high cumulative adiposity had HRs of 1.36–1.51 compared with those with low levels of both. RCS analyses showed an overall increase in CVD risk at higher exposure levels, without evidence of nonlinearity. Incremental prediction gains were small. Conclusions Higher cumulative HbA1c–adiposity products were associated with subsequent CVD, and participants with high levels of both components had higher risk. These measures may help describe joint glycemic and adiposity exposure in cohort studies. A clear predictive advantage over models containing both components separately was not demonstrated, and clinical utility remains to be established.
Authors
- Hao GuoHua
- X. Liu
- 谷晓岚
- 秦俊嫄 (ORCID: https://orcid.org/0009-0001-3596-8711)
- Shen Li (ORCID: https://orcid.org/0000-0002-3022-1141)
- Lan Luo (ORCID: https://orcid.org/0009-0008-8204-7975)
- Yingzhuo Dong (ORCID: https://orcid.org/0009-0002-4181-2147)
- Jia Li (ORCID: https://orcid.org/0000-0003-3152-3253)
- Zhengnan Gao
- Wei Zhao
- Xinyu Li
Institutions
- Dalian Medical University (CN)
- Dalian University of Technology (CN)
- Dalian University (CN)
- Dalian Municipal Central Hospital (CN)
- Affiliated Zhongshan Hospital of Dalian University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fendo.2026.1985370
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00